[The converting enzyme inhibitors in myocardial infarct in acute phase. Experimental data and prospects].
Salvetti
A
A
Cattedra di Terapia Medica Sistematica, Clinica Medica 1, Università degli Studi di Pisa.
Di Legge
V
V
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D005609:Free Radicals; D006801:Humans; D007610:Kallikreins / Q000502:physiology; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D015425:Myocardial Reperfusion / Q000009:adverse effects; D009336:Necrosis; D011803:Quinine; D012084:Renin-Angiotensin System
D000806:Angiotensin-Converting Enzyme Inhibitors; D005609:Free Radicals; D011803:Quinine; D007610:Kallikreins
Gli inibitori dell'enzima convertitore nell'infarto miocardico in fase acuta. Dati sperimentali e prospettive.